Imbed Biosciences
Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.
Industries
Nr. of Employees
small (1-50)
Imbed Biosciences
2241 Pinehurst Dr., Middleton, WI 53562
Awards
Thin-film dressing with silver and cerium for stabilizing burn wounds
Funding (ceiling)
$375,000
Award Year
2022
Bioresorbable Ultrathin Matrix Delivering Silver and Gallium to Wounds for Synergistic Killing of Biofilm for Prolonged Field Care.
Funding (ceiling)
$1,999,481
Award Year
2021
Navy Multi-Topic 2021 - Advanced Biomedical Product Development in Support of Naval Operations
Antibiofilm bioresorbable matrix to stabilize combat burn and trauma wounds in the field.
Funding (ceiling)
$440,620.24
Award Year
2021
Far-Forward Burn Treatment
Antibiofilm bioresorbable matrix to stabilize combat burn and trauma wounds in the field
Funding (ceiling)
$3,788,054.58
Award Year
2021
Patents
Products
Surgaflex
Ultrathin synthetic polymer matrix composed of polyvinyl alcohol with a surface coating containing ionic and metallic silver; designed for acute and surgical wounds to provide conformal coverage and antimicrobial activity.
PelashieldAM
Multilayer synthetic polymer matrix (polyelectrolyte multilayer) engineered for management of burn wounds, providing contouring, moisture control, and antimicrobial inhibition of bacterial growth.
Microlyte Matrix
Multi-layer synthetic polymeric skin substitute that absorbs fluid to maintain moist wound healing and contains ultra-low amounts of ionic and metallic silver for antimicrobial protection; available in multiple sizes and configurations.
Microlyte Ag/Lidocaine
Combination matrix product integrating ionic/metallic silver for antimicrobial action with incorporated lidocaine hydrochloride for local anesthetic release from the dressing.
Surgaflex
Ultrathin synthetic polymer matrix composed of polyvinyl alcohol with a surface coating containing ionic and metallic silver; designed for acute and surgical wounds to provide conformal coverage and antimicrobial activity.
PelashieldAM
Multilayer synthetic polymer matrix (polyelectrolyte multilayer) engineered for management of burn wounds, providing contouring, moisture control, and antimicrobial inhibition of bacterial growth.
Microlyte Matrix
Multi-layer synthetic polymeric skin substitute that absorbs fluid to maintain moist wound healing and contains ultra-low amounts of ionic and metallic silver for antimicrobial protection; available in multiple sizes and configurations.
Microlyte Ag/Lidocaine
Combination matrix product integrating ionic/metallic silver for antimicrobial action with incorporated lidocaine hydrochloride for local anesthetic release from the dressing.
Expertise Areas
- Wound care therapeutics and skin substitutes
- Synthetic biomaterials for wound management
- Antimicrobial dressing development
- Drug-device combination product development
Key Technologies
- Synthetic polymer matrix fabrication
- Polyvinyl alcohol (PVA)-based hydrophilic matrices
- Polyelectrolyte multilayer assembly
- Ionic and metallic silver antimicrobial incorporation
Key People
News & Updates
January 27 – February 1, Maui, Hawaii
First antimicrobial wound dressing with integrated lidocaine to manage painful wounds.
January 27 – February 1, Maui, Hawaii
First antimicrobial wound dressing with integrated lidocaine to manage painful wounds.